Every 10-Q that Healthcare Triangle Inc (HCTI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HCTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCTI filings page.
Healthcare Triangle, Inc. reported sharply higher revenue but significantly larger losses for the period ended June 30, 2026. Net revenue for the quarter rose to $9,193 from $3,558 a year earlier, and for the first six months to $19,046 from $7,263, driven primarily by the newly acquired AI-powered Customer Engagement Services segment (Teyame and Datono).
Despite growth, profitability weakened. The company posted a six-month loss from operations of $7,696 versus $2,757 in 2025 and a six-month net loss of $10,615 versus $3,068. Operating cash flow was negative $7,697, and cash and cash equivalents declined to $1,906 from $7,625 at year-end 2025.
Total assets increased to $73,640 (from $22,736) as a result of the Teyame/Datono acquisition, including $54,825 of other intangible assets and $2,946 of goodwill. The capital structure now includes $8,103 of bank debt, $3,724 of 2026 convertible notes at fair value, and $49,099 of stockholders’ equity, with new Series C preferred stock and common stock consideration tied to the acquisition. Management acknowledges past losses but concludes that existing net assets, a stockholder-approved $50,000 Equity Line of Credit, and an at-the-market program provide sufficient liquidity for at least twelve months.
Healthcare Triangle, Inc. reported much larger scale in the quarter ended March 31, 2026, following its acquisition of Teyame and Datono. Net revenue rose to $9.86 million from $3.70 million, mainly from the new Customer Engagement Services segment. Gross margin improved to $2.39 million, but the company recorded a larger net loss of $6.20 million, versus $1.70 million a year earlier, driven by higher operating expenses, amortization and a $2.44 million loss from changes in fair value of 2025 convertible notes.
Total assets increased to $80.16 million, reflecting recognition of $55.22 million in other intangible assets and $2.95 million of goodwill tied to acquisitions. Cash and cash equivalents were $4.32 million, with negative operating cash flow of $6.86 million and $6.02 million used in investing mainly for the Teyame acquisition, partially offset by $9.48 million provided by financing activities.
At March 31, 2026, total current and long‑term liabilities were $27.47 million, including short‑term borrowings and debt with credit institutions of $9.09 million, and contingent consideration of $5.00 million. Stockholders’ equity expanded to $52.70 million, aided by equity issuances, preferred stock arrangements and conversion of 2025 debentures into common shares. After a 1‑for‑60 reverse stock split, there were 2,027,783 common shares outstanding as of May 13, 2026. Management acknowledges prior operating losses and negative cash flows but concludes, based on net assets and subsequent equity proceeds, that it has sufficient resources to meet obligations for at least twelve months.
Healthcare Triangle, Inc. reported Q3 results with net revenue of $3,489 (up 45% year over year) and a net loss of $1,906. For the nine months, revenue was $10,752 (up 13%), with a net loss of $4,973. Segment mix shifted toward Software Services, while Managed Services declined.
Liquidity and the balance sheet changed markedly. Cash and cash equivalents were $1,629 as of September 30, 2025. Net cash used in operating activities was $9,689, offset by $12,587 of net financing cash inflows primarily from equity issuance. Total assets rose to $13,838 from $1,961 at year‑end, reflecting the June 16 acquisition of Niyama Healthcare/Ezovion (purchase price $5,700, including cash, 1,388,041 restricted shares valued at $3,000, and up to $1,200 earn‑out). Stockholders’ equity improved to $8,726 from a deficit.
The company effected a 1‑for‑249 reverse stock split on August 1, 2025. Short‑term borrowing under the Seacoast facility was $1,530, and convertible notes were eliminated through conversion and repayment. As of November 13, 2025, 7,261,344 common shares were outstanding.
Healthcare Triangle, Inc. (HCTI) reported a quarter showing a completed acquisition, a large reverse stock split and continued operating losses. On June 16, 2025 the company closed an asset acquisition for $5.7 million comprised of $1.5 million cash (with $1.2 million paid at closing and $300,000 payable later), restricted common stock equal to $3.0 million issued at roughly $2.16–$2.17 per share, and up to $1.2 million of contingent earn-outs. The Company effected a 1-for-249 reverse split of common stock on August 1, 2025 and adjusted basic and diluted earnings for all periods. Cash and cash equivalents changed by +$3,208 (net increase) for the period reported. The company reported net losses reflected in negative basic and diluted EPS (examples shown: $(0.58) and $(70.72) in one presentation and $(2.56) and $(171.85) in another), high customer concentration in receivables (five customers represented ~52% and ~72% of accounts receivable), and a financing that produced net proceeds of approximately $13,676 after fees.